Page last updated: 2024-10-30

lamotrigine and Bone Diseases, Metabolic

lamotrigine has been researched along with Bone Diseases, Metabolic in 3 studies

Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.

Research Excerpts

ExcerptRelevanceReference
"To determine whether long-term treatment with valproate (VPA) and/or lamotrigine (LTG) in children with epilepsy is associated with altered growth and/or bone metabolism."7.71Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. ( Atkinson, SA; Guo, CY; Ronen, GM, 2001)
" We previously reported biochemical evidence of increased bone turnover in premenopausal women with epilepsy on phenytoin monotherapy compared with those on carbamazepine, lamotrigine, and valproate."3.74Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. ( McMahon, DJ; Morrell, MJ; Pack, AM; Randall, A; Shane, E, 2008)
"To determine whether long-term treatment with valproate (VPA) and/or lamotrigine (LTG) in children with epilepsy is associated with altered growth and/or bone metabolism."3.71Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. ( Atkinson, SA; Guo, CY; Ronen, GM, 2001)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SH1
Lee, JW1
Choi, KG1
Chung, HW1
Lee, HW1
Pack, AM1
Morrell, MJ1
Randall, A1
McMahon, DJ1
Shane, E1
Guo, CY1
Ronen, GM1
Atkinson, SA1

Other Studies

3 other studies available for lamotrigine and Bone Diseases, Metabolic

ArticleYear
A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
    Epilepsy & behavior : E&B, 2007, Volume: 10, Issue:2

    Topics: Adolescent; Adult; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcitriol;

2007
Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
    Neurology, 2008, Apr-29, Volume: 70, Issue:18

    Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, M

2008
Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
    Epilepsia, 2001, Volume: 42, Issue:9

    Topics: Adolescent; Anticonvulsants; Bone and Bones; Bone Density; Bone Diseases, Developmental; Bone Diseas

2001